Capsugel Belgium NV

About Capsugel Belgium NV

Lonza is the preferred global partner to the pharmaceutical, biotech and nutrition markets. We work to prevent illness and enable a healthier world by supporting our customers to deliver new and innovative medicines that help treat a wide range of diseases. We achieve this by combining technological insight with world-class manufacturing, scientific expertise and process excellence. These enable our customers to commercialize their discoveries and innovations in the healthcare sector.

Lonza’s industry-leading Capsugel® capsules and encapsulation technologies, formulation know-how and science-backed ingredients combined with our customer-focused services, provide unique and innovative solutions for nutraceutical companies.

Founded in 1897 in the Swiss Alps, today Lonza operates across three continents. With approximately 14,000 full-time employees, we are built from high-performing teams and of individual talent who make a meaningful difference to our own business, as well as to the communities in which we operate. The company generated sales of CHF 4.5 billion in 2020 with a CORE EBITDA of CHF 1.4 billion.  Find out more on 

  • BE
  • 2015
    On CPhI since
Contact info
Meet us at

CPhI Worldwide 2021

Fiera Milano, Milan, Italy
9-11 November 2021

CPhI & PMEC India 2021

India Expo Centre, Greater Noida, Delhi NCR
24 - 26 November 2021

Products from Capsugel Belgium NV

  • Vcaps® Plus capsules

    Product Vcaps® Plus capsules

    An immediate-release HPMC capsule, without gelling agents. Vcaps® Plus capsules offer excellent dissolution profile with pH-independent performance, standard or low-moisture content, great machinability and visual quality. Also available in TiO2 free and with food colorants.
  • Zephyr(TM) Dry-Powder Inhalation capsules

    Product Zephyr(TM) Dry-Powder Inhalation capsules

    Custom inner surface properties, customized moisture levels and more stringent microbial limits all designed to optimize inhalant end-product performance. Available in gelatin, gelatin-PEG, Capsugel® Vcaps® and Capsugel® Vcaps® Plus.
  • DBcaps® capsules

    Product DBcaps® capsules

    DBcaps® capsules were developed with a tamper-evident design to specifically address the clinical trial challenges of testing without bias. The wider diameter of opaque DBcaps® allows containment and blinding of large-diameter or uniquely-shaped tablets or other comparator products, while their shorter length makes them easier to swallow. Available in gelatin and HPMC.
  • Enteric capsules

    Product Enteric capsules

    Capsule technology that simplifies enteric drug delivery implementation. It offers an enteric-release profile to the upper gastro-intestinal tract that meets the disintegration requirements for delayed-release capsules from the European, US and Japanese Pharmacopoeia. The pharmaceutical grades of cellulosic derivatives used in Vcaps® Enteric capsules have extensive market precedence for use in providing enteric protection. ​

  • Colorista® capsules

    Product Colorista® capsules

    An optimized tool for formulation development enabling compatibility studies before deciding on the final color for the commercial drug products. Available in gelatin and HPMC.​
  • Press-Fit®/ XPress-Fit® gelcaps

    Product Press-Fit®/ XPress-Fit® gelcaps

    Press-Fit® and XPress-Fit® Gelcaps utilize a Capsugel®  technology that is difficult to mimic and enables brands to create a new product look without having to reformulate their product. Flexible gelcaps are stretched around a caplet of specified shape and dimension using a patented cold-shrink process.
  • Vcaps® Gen C capsules

    Product Vcaps® Gen C capsules

    Vcaps® Gen C is a high-quality capsule based on a carrageenan gelling agent formulation. It offers a good dissolution profile with no discernible lag time, great machinability and visual quality. ​
  • Coni-Snap® Sprinkle capsules

    Product Coni-Snap® Sprinkle capsules

    Designed to be easily opened by patients and caregivers, these capsules are ideal for pediatric and geriatric populations. Available in gelatin and HPMC.​
  • Coni-Snap® Sigma Series Hard Gelatin capsules

    Product Coni-Snap® Sigma Series Hard Gelatin capsules

    Hard capsules that meet the tightest requirements for visual and print quality though the combination of process control and on-line inspection technology.
  • Coni-Snap® Hard Gelatin capsules

    Product Coni-Snap® Hard Gelatin capsules

    The reliable and outstanding performance of Coni-Snap® hard gelatin capsules has made them a product of choice for biopharmaceutical companies since their unique locking closure was introduced. Designed and engineered to perform, they are a reliable and widely used capsule.
  • UC-II® undenatured type II collagen ingredient

    Product UC-II® undenatured type II collagen ingredient

    The global population continues to age, however mobility is no longer just a concern that affects seniors; consumers across the generations are now looking for efficacious products to promote aging well and support peak physical perfomance. Healthy joints play a pivotal role in protecting mobility as we get older and ensuring recovery after exercise. Backed by three published clinical trials, Lonza’s UC-II® undenatured type II collagen ingredient has been shown to support joint comfort, flexibility and mobility. The ingredient can also be combined with other ingredients such as vitamins C, D and K2, manganese and copper for additional joint and bone health benefits. 

  • Lonza Engine equipment

    Product Lonza Engine equipment

    Lonza Engine™ offers state-of-the-art equipment designed to address the needs of customers throughout the entire drug development process including:  ​  ​

    ·         Liquid-filled hard capsules filling and sealing equipment: support for lipid-based formulations to improve the bioavailability of poorly soluble compounds. ​  
    ·         Powder micro-dosing: precise filling of capsules without excipients or bulking agents.  
    ·         A partnership with a market leader in capsule and dosage form technologies.  

    A comprehensive full equipment line with offerings for bioavailability enhancement, clinical development, small batches, and commercial capsule filling

Capsugel Belgium NV Resources

  • News The Top 5 Industry Content Reads on CPhI Online

    If you’re looking for news, product information and market trends from leading pharma companies, the Company Showcases are a great resource for buyers who want to stay up to date, browse product portfolios and find the right partner. 

    The Company Showcase profiles offer a library of free to access, downloadable content, including videos and webinars, reports, whitepapers and product brochures, from the Pharma suppliers and service providers you’d look to meet at our events.

  • Brochure Capsugel®️ Vcaps®️ Plus capsules

    An immediate-release capsule for pharmaceutical products in HPMC only, without gelling agents. Vcaps®️ Plus capsules offer excellent dissolution profile with pH-independent performance, standard or low moisture content, great machinability and visual quality.
  • Brochure Capsugel®️ R&D Portfolio

    The Capsugel®️ R&D Portfolio addresses key concerns of R&D departments. Download the brochure to learn more about PCcaps®️ capsules for pre-clinical studies, DBcaps®️ capsules for double-blind clinical trials, the excellent dissolution profile of Vcaps®️ Plus capsules, Vcaps®️ Enteric capsules that simplify enteric drug delivery implementation, and Colorista®️ capsules, the perfect tool for flexible and time-efficient development of new products.  
  • Brochure Capsugel®️ Zephyr™️ Dry-Powder Inhalation Capsule Portfolio

    Dry-powder inhalation (DPI) technology offers a favorable drug development opportunity for respiratory or systemic drug delivery. Delivering a uniform dose in a portable, easy-to-use system, capsule-based DPI devices are a simple and cost-effective way to deliver inhalable medication. Capsugel® Zephyr™ is Lonza’s customizable dry-powder inhalation capsule portfolio that is optimized to provide superior performance and compatibility between the capsule/device and capsule/formulation.
  • Brochure High-quality capsules for the medicines of tomorrow

    The Capsugel® product portfolio is engineered to help overcome key product challenges with proven performance in products you trust. We are focused on quality and compliance in everything we do, from raw material sourcing to manufacturing and follow-up service. Our ongoing commitment to Six Sigma principles helps to minimize variability, improve the quality of our processes, and lead us toward the ultimate goal of zero defects for our products.
  • Brochure The Lonza Engine™ Alliance Program

    Our capsule filling equipment partnership program allows customers to match the best equipment for their process with the high-quality and performance of Capsugel®️ capsules.
  • Brochure UC-II®️ Undenatured Type II Collagen

    Breakthrough in the competitive joint health & mobility category with UC-II®️ Undenatured Type II Collagen. This joint health ingredient is clinically proven to reduce joint discomfort and increase mobility by helping to repair and rebuild cartilage.
  • Whitepaper Ingredients and formulation – evolving opportunities and challenges

    Ingredients are the lifeblood of the pharmaceutical and nutraceutical industries. They connect today’s cutting-edge medicine and consumer products makers with their origins in the chemicals sector of the late nineteenth century. While ingredients play a major part in determining whether a pharmaceutical or nutraceutical product is effective, they do not do it alone. How an ingredient is formulated is critical to the success of prescription medicine or OTC product, both therapeutically and from a commercial standpoint. This report looks at how the pharmaceutical and consumer health industries have risen to the challenge of making formulations that comply with evolving efficacy and safety demands while satisfying the needs of patients and consumers.
  • Video Value Added Excipients to Unlock the Potential of APIs

    This webinar originally aired as part of CPhI Discover - 17-28 May 2021 The humble excipient can play an important role in improving drug formulation, particularly in terms of solubility and stability. This session will explore how to add value to your drug development. Discussion points: The Vital Role Excipients play in producing new drugs and consumer products. An overview of Excipient Quality and Impact on Formulation Excipients Added to Solid Oral Dosage Forms to Improve Drug Solubility and/or Dissolution Latest Developments, demands & trends in the Excipients Market Examples of some Solutions, technologies, and regulatory changes happening on a global scale
  • Video Drug Delivery & Development: Overcoming Tomorrow’s Formulation Challenges

    This panel aims to provide an overview of the latest approaches to formulation and process challenges for drug development, manufacturing and supply, Highlighting a customized approach to optimize the performance of the end product. Our expert panel members will be sharing their views and experiences on the following key topics: Dry-powder inhalation (DPI) technology for favourable drug development and as a cost-effective and straightforward way to deliver inhalable medication, Drug Delivery Technologies for Women's Health Applications and 3D printing technologies reshaping drug discovery and pharmaceutical development and manufacturing. This presentation was originally aired as part of the CPhI Festival of Pharma.